We presented our comments today in the context of the 10-year health care plan. The 10-year health care plan has a national pharmaceutical strategy, and an important element of that for the provinces is faster access to generics.
We're trying to save money. We've reached accords with a number of provinces to do just that. If they're delayed in getting access to our products, their costs are going to go up. I think that's an important aspect of the health care system.